Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhage

J Neurol Sci. 2005 Mar 15:229-230:249-54. doi: 10.1016/j.jns.2004.11.041. Epub 2004 Dec 29.

Abstract

Spontaneous intracerebral hemorrhage (ICH) is one of the most recognized complications of cerebral amyloid angiopathy (CAA), but little is known about the molecular pathogenesis of this life-threatening complication. In this review, we present preliminary evidence which suggests that the extracellular-matrix-degrading protease, matrix metalloproteinase-9 (MMP-9), may play a role in the development of spontaneous ICH resulting from CAA. The amyloid-beta peptide (Abeta) induced the synthesis, cellular release, and activation of MMP-9 in murine cerebral endothelial cells (CECs), resulting in increased extracellular matrix (ECM) degradation. Furthermore, in a mouse model of CAA (APPsw transgenic mice), MMP-9 immunoreactivity was observed in amyloid-laden cerebral vessels in aged APPsw mice but not in young APPsw or aged wild-type mice. More extensive MMP-9 immunostaining was present in amyloid-laden vessels with evidence of microhemorrhage. These results suggest that increased vascular MMP-9 expression, stimulated by Abeta, may play a role in the pathogenesis of spontaneous intracerebral hemorrhage (ICH) in patients with CAA.

Publication types

  • Review

MeSH terms

  • Animals
  • Cerebral Amyloid Angiopathy / complications
  • Cerebral Amyloid Angiopathy / pathology*
  • Cerebral Hemorrhage / etiology
  • Cerebral Hemorrhage / pathology*
  • Endothelium, Vascular / pathology
  • Extracellular Matrix / pathology
  • Humans
  • Immunohistochemistry
  • Matrix Metalloproteinase 9 / physiology*
  • Mice
  • Mice, Transgenic

Substances

  • Matrix Metalloproteinase 9